Liver Cancer & Metastases Treatment in Hyderabad

Overview

Understanding Liver Cancer & Liver Metastases

Liver malignancies fall into two broad categories: primary liver cancer — most commonly hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma — and secondary liver metastases from other cancers, most importantly colorectal liver metastases (CLM). Each requires a distinct surgical approach and multidisciplinary management strategy.

Hepatocellular carcinoma (HCC) arises predominantly in livers damaged by hepatitis B/C, cirrhosis, or fatty liver disease. Surgical resection offers the best survival for patients with adequate liver function reserve (Child-Pugh A) and no portal hypertension. For patients with underlying cirrhosis who cannot be resected, liver transplantation (within Milan criteria) or ablative therapies are options.

Colorectal liver metastases (CLM) deserve particular emphasis: they are resectable in 15–20% of patients, and resection offers 5-year survival rates of 35–50% — dramatically better than chemotherapy alone. The “resectability” concept has evolved: the question is not “how much liver to remove” but “how much liver will remain” — a future liver remnant (FLR) of ≥30% (≥40% in cirrhotic livers) is required for safe resection.

At a Glance

Primary liver cancer types: HCC (most common), intrahepatic cholangiocarcinoma
Risk factors for HCC: Hepatitis B/C, cirrhosis, NASH, alcohol, aflatoxin
Most common liver metastases: Colorectal (most resectable), gastric, neuroendocrine
CLM resection survival: 35–50% 5-year — far superior to chemotherapy alone
Minimum liver remnant: ≥30% FLR (≥40% in cirrhosis) for safe major hepatectomy

Warning Signs

Symptoms of Liver Cancer & Metastases

Liver tumours are often asymptomatic until large — surveillance in at-risk patients is essential for early detection.

🤰
Right Upper Abdominal Pain

Dull, aching right upper quadrant or shoulder-tip pain from liver capsule distension.

💛
Jaundice

Yellow discolouration of skin/eyes from bile duct compression or liver parenchymal replacement.

⚖️
Weight Loss & Fatigue

Unintentional weight loss, anorexia, and progressive fatigue.

🤢
Nausea & Poor Appetite

Generalised symptoms from tumour effects on hepatic function.

🔍
Incidental CT Finding

Liver lesions discovered on staging CT for colorectal cancer — the most common scenario for CLM.

📊
Elevated AFP / CEA

Elevated AFP (HCC), rising CEA (colorectal metastases), or elevated CA19-9 (cholangiocarcinoma).

Our Approach

Surgical Treatment for Liver Cancer

Liver resection for HCC aims to remove the tumour with a 1 cm clear margin while preserving adequate functional liver remnant. For large tumours or bilobar disease, portal vein embolisation (PVE) can be used to grow the future liver remnant before resection. Laparoscopic hepatectomy — for tumours in favourable segments — reduces blood loss, hospital stay, and recovery time.

For colorectal liver metastases, the surgical strategy is determined by the number, size, and distribution of lesions, and the adequacy of the future liver remnant. Simultaneous colorectal primary and liver resection can be performed in selected patients. For patients with technically resectable but too many lesions, staged resection — first clearing the primary tumour, then the liver — combined with conversion chemotherapy is the strategy.

Intraoperative ultrasound is used during all liver resections to identify lesions not visible on CT and to guide surgical planes. I review every case in a multidisciplinary liver oncology board before proceeding, and I am happy to see patients referred from other teams for a second opinion on resectability.

Surgical Procedure
Liver Metastases Resection

Surgical resection of colorectal and other liver metastases — offering curative potential in eligible patients.

Learn more →

Surgical Procedure
CRS + HIPEC for Liver Surface Disease

Combined peritoneal and liver surface treatment for patients with both hepatic and peritoneal involvement.

Learn more →

Why Choose Us

Expertise You Can Trust

Dr. Mohammed Imaduddin brings internationally trained surgical skills and a patient-first philosophy to every case.

500+
Complex Oncological Surgeries Performed
15+
Years in Surgical Oncology
3
International Training Centres (Hannover, Charité, AIIMS)
FACS
Fellow of the American College of Surgeons

Common Questions

Frequently Asked Questions

Common questions from patients with liver tumours and liver metastases.

Can liver metastases be cured with surgery?
Yes — for colorectal liver metastases specifically, surgery offers genuine curative potential. The 5-year survival after R0 resection of CLM ranges from 35–50%. Other liver metastases (e.g., from neuroendocrine tumours) can also benefit from surgery. The criteria for resectability are: ability to achieve clear (R0) margins, adequate future liver remnant (≥30%), and no unresectable extrahepatic disease. Do not accept “the cancer has spread to the liver” as the end of the conversation — get a specialist evaluation.
How much liver can be safely removed?
The liver has remarkable regenerative capacity — it can regenerate to near-normal volume within 6–8 weeks after major resection. The minimum required future liver remnant (FLR) is 30% of total liver volume in a healthy liver, and 40% in a cirrhotic or chemotherapy-damaged liver. For patients with an insufficient FLR, portal vein embolisation (PVE) — a radiological procedure blocking blood supply to the liver segment to be removed — stimulates the remaining liver to hypertrophy over 4–6 weeks before surgery.
What is Child-Pugh score and why does it matter?
The Child-Pugh score (A, B, C) assesses liver functional reserve in patients with chronic liver disease, using parameters including bilirubin, albumin, INR, ascites, and encephalopathy. Child-Pugh A patients (score 5–6) have adequate liver function for hepatic resection. Child-Pugh B/C patients have limited reserve and are at higher risk — resection may not be safe, and liver transplantation evaluation is appropriate for eligible patients.
What is the difference between primary liver cancer and liver metastases?
Primary liver cancer arises from the liver cells themselves — HCC from hepatocytes, cholangiocarcinoma from bile duct cells. Liver metastases are secondary cancers that have spread to the liver from another primary site (most commonly colorectal, but also breast, lung, neuroendocrine, and gastric). The distinction matters because treatment and prognosis differ significantly. A liver biopsy or contrast-enhanced MRI/CT can usually differentiate them, though biopsy is avoided if surgical resection is planned.
I was told my liver metastases are “unresectable”. Is that final?
Not necessarily. Resectability is a dynamic concept — it changes with treatment. Conversion chemotherapy (FOLFOX, FOLFIRI with bevacizumab or cetuximab) can downstage 20–30% of initially unresectable CLM to allow surgery. Portal vein embolisation can increase a small FLR to permit resection. Staged two-stage hepatectomy can remove bilobar disease. I recommend that any patient told their liver metastases are “unresectable” seek evaluation at a specialist liver surgery centre.

Ready to Discuss Your Case?

Every cancer journey is different. I offer a detailed, unhurried consultation to help you understand your options and make informed decisions.

Book via WhatsApp
View Clinic Locations